iSERA Lifesciences rights issue

As per the ratio of 25:1, the issue price of the shares under iSERA Lifesciences’s right issue on the record date of 24-10-2025 is 10 per equity share.

You can apply for iSERA Lifesciences’s right issue online if your bank supports the Applications Supported by Blocked Amount (ASBA) process.
For offline, iSERA Lifesciences’s Registrar and Transfer Agent (RTA) sends the Composite Application Form (CAF) to each shareholder entitled to receive the Rights Issue. Fill out and submit the form to a Self-Certified Syndicate Bank (SCSB) branch (WEB).
Alternatively, you can use your bank account sharing the same PAN number as your Choice Demat account to apply for iSERA Lifesciences's rights issue.

The record date for iSERA Lifesciences rights issue 2025 is 24-10-2025

The last day to apply for iSERA Lifesciences’s rights issue is 24-10-2025. This date typically falls within a period of 15 to 30 days, from the Rights Issue Opening Date, which in this case is 03-10-2025.

Yes, subscribing to iSERA Lifesciences’s right issue has certain tax implications:

1. Subscription: There’s no immediate tax liability. The cost of acquisition is the subscription price plus transaction charges.
2. Capital Gains on Sale:
   • Short-Term: Gains from shares sold within 12 months are taxed at 20%.
   • Long-Term: Gains from shares held over 12 months are taxed at 12.5% (exceeding ₹1.25 lakh annually).
3. Renunciation:
   • Selling rights entitlement attracts capital gains tax.
   • Gifted rights have no immediate tax but may impact the recipient later.
4. Dividend Income: Taxed at the shareholder's applicable slab rate.

You may consult a tax professional or review the latest tax laws for specific advice.